Caldera Therapeutics Funding: $113M Raised, Series A (2026)
Caldera Therapeutics is a Biotech company based in Cambridge, MA. It has raised $113M in total funding. Latest round: Series A.
Caldera Therapeutics funding overview
Caldera Therapeutics is a Biotech company based in Cambridge, MA. Caldera Therapeutics has raised $113M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2026. The round record for Caldera Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Atlas Venture, LAV, venBio, Omega Funds, Wellington Management, Janus Henderson Investors. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Caldera Therapeutics funding
How much has Caldera Therapeutics raised?
Caldera Therapeutics has raised $113M in total disclosed funding across the rounds on record.
Who has invested in Caldera Therapeutics?
Atlas Venture, LAV, venBio, Omega Funds, Wellington Management, Janus Henderson Investors are named among the investors backing Caldera Therapeutics.
What was the latest Caldera Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2026.
Where is Caldera Therapeutics based?
Caldera Therapeutics is based in Cambridge, MA.
What sector does Caldera Therapeutics operate in?
Caldera Therapeutics is tracked under Biotech from Cambridge, MA, with $113M in disclosed funding.
When did Caldera Therapeutics last raise?
The last disclosed Caldera Therapeutics round closed in January 2026 at Series A.
Round data for Caldera Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.
